Peregrine Capital Management LLC Catalent, Inc. Transaction History

Peregrine Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	SELL	$44.2 - $50.2 $37,835 - $42,971	-856 Reduced 3.96%	20,765 $945,000
Q2 2023 Jul 26, 2023	BUY	$31.86 - $67.26 $273,040 - $576,418	8,570 Added 65.67%	21,621 $937,000
Q1 2023 Apr 26, 2023	SELL	$45.44 - $74.26 $192,438 - $314,491	-4,235 Reduced 24.5%	13,051 $857,000
Q4 2022 Jan 10, 2023	BUY	$41.39 - $81.0 $80,089 - $156,735	1,935 Added 12.61%	17,286 $778,000
Q4 2021 Jan 31, 2022	BUY	$119.57 - $139.07 $211,280 - $245,736	1,767 Added 13.01%	15,351 $1.97 Million
Q4 2020 Jan 19, 2021	BUY	$85.88 - $105.36 $1.17 Million - $1.43 Million	13,584 New	13,584 $1.41 Million

469

148M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Peregrine Capital Management LLC with notifications on news.